Primary hyperoxaluria type 1
Common Name(s)
Primary hyperoxaluria type 1
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Primary hyperoxaluria type 1" for support, advocacy or research.
To seek the cause, improve the clinical treatment and discover the cure of hyperoxaluria and oxalate stone disease and enhance the quality of life of patients and their families.
How do you compare to others with this condition?
Privately answer questions about your health. Let resources, you select, come to you.
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Primary hyperoxaluria type 1" for support, advocacy or research.
To seek the cause, improve the clinical treatment and discover the cure of hyperoxaluria and oxalate stone disease and enhance the quality of life of patients and their families.
http://www.ohf.org/Recommended Apps
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Finding the right clinical trial for Primary hyperoxaluria type 1 can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.
Scientific Literature
Articles from the PubMed Database
Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Primary hyperoxaluria type 1" returned 49 free, full-text research articles on human participants.
First 3 results:
Journal:
Primary hyperoxaluria type 1 (PH1), is a rare and heterogeneous disease and one of major causes of renal insufficiency in Tunisia, caused by mutations in the AGXT gene. 33-34InsC mutation, was mainly described in children with a severe clinical feature leading to early death, but ...
Journal: Saudi J Kidney Dis Transpl. ;27(4):791-4.
Primary hyperoxaluria Type-1 (PH-1) is caused by a deficiency of alanine-glyoxylate aminotransferase manifesting as urolithiasis, nephrocalcinosis, and end-stage renal disease (ESRD). Among treatment options, best outcomes have been achieved by sequential liver-kidney transplantation ...
Journal: Am. J. Nephrol.. 2016 ;43(4):293-303.
Primary hyperoxaluria type 1 (PH1) and idiopathic hypercalciuria (IHC) are stone-forming diseases that may result in the formation of calcium (Ca) oxalate (Ox) stones, nephrocalcinosis, and progressive chronic kidney disease (CKD). Poorer clinical outcome in PH1 is segregated by the ...
To view other free, full-text articles on human participants, please click on the link below.
Reviews from the PubMed Database
Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Primary hyperoxaluria type 1" returned 3 free, full-text review articles on human participants.
First 3 results:
Journal: Biochim. Biophys. Acta. 2006 Dec;1763(12):1776-84.
Primary hyperoxaluria type 1 (PH1) is an atypical peroxisomal disorder, as befits a deficiency of alanine:glyoxylate aminotransferase (AGT), which is itself an atypical peroxisomal enzyme. PH1 is characterized by excessive synthesis and excretion of the metabolic end-product oxalate ...
Journal: Am. J. Nephrol.. ;25(3):303-10.
Primary hyperoxaluria type 1 (PH1) is a rare autosomal-recessive disorder caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase (AGT). AGT deficiency results in increased synthesis and excretion of the metabolic end-product oxalate and deposition ...
To view other free, full-text review articles on human participants, please click on the link below.
Symptoms, Diagnosis, and Treatment
https://ghr.nlm.nih.gov/gene/AGXT
https://ghr.nlm.nih.gov/gene/GRHPR
https://ghr.nlm.nih.gov/gene/HOGA1
https://ghr.nlm.nih.gov/condition/leukocyte-adhesion-deficiency-type-1
https://ghr.nlm.nih.gov/condition/distal-arthrogryposis-type-1
https://ghr.nlm.nih.gov/condition/type-1-diabetes
https://ghr.nlm.nih.gov/condition/atelosteogenesis-type-1
https://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-1
https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-1
https://ghr.nlm.nih.gov/condition/otopalatodigital-syndrome-type-1
https://ghr.nlm.nih.gov/condition/optic-atrophy-type-1
https://ghr.nlm.nih.gov/condition/pseudohypoaldosteronism-type-1
https://ghr.nlm.nih.gov/condition/primary-myelofibrosis
https://ghr.nlm.nih.gov/condition/primary-carnitine-deficiency
https://ghr.nlm.nih.gov/condition/acute-necrotizing-encephalopathy-type-1
https://ghr.nlm.nih.gov/condition/primary-localized-cutaneous-amyloidosis
https://ghr.nlm.nih.gov/condition/autosomal-recessive-primary-microcephaly
https://ghr.nlm.nih.gov/condition/primary-sclerosing-cholangitis
https://ghr.nlm.nih.gov/condition/primary-coenzyme-q10-deficiency
Clinical Trial Information This information is provided by ClinicalTrials.gov
Condition Summary: Primary Hyperoxaluria Type 1 (PH1)
Condition Summary: Primary Hyperoxaluria
Finding the right clinical trial for Primary hyperoxaluria type 1 can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.